CombiMatrix is now using BioDiscovery’s NxClinical software for analysis, management, and interpretation of copy number events in its clinical workflow.
Recognized leader in research and education, and one of the top pediatric providers in the Midwest recently started using NxClinical.
See how Nexus Copy Number has been used at North Carolina State University to detect copy number changes by CGH analysis in Canines.
A genomics services provider for clinical trials, testing, and research will now be working with BioDiscovery in a co-marketing partnership.
NxClinical 2.0 is a flexible, platform-agnostic database solution for efficient analysis, interpretation, and reporting of variations.
NxClinical focuses on improving efficiency and quality through multi-user collaborative communication, audit-trail features, and automation.
BioDiscovery awarded grant to make further discoveries into tumorigenesis and disease progression and provide a validation set for studies.
Nexus Copy Number for Affymetrix is for data generated by Affymetrix’ genetic analysis platforms in cancer research. Learn more!
Cancer Genetics, Inc. and BioDiscovery announces expansion of the Nexus Copy Number Discovery platform to better predict cancer outcomes.